On June 2, 2022 GlycoMimetics, Inc. (Nasdaq: GLYC) reported that the Company will participate at the Jefferies 2022 Healthcare Conference, on June 8th, in New York, NY (Press release, GlycoMimetics, JUN 2, 2022, View Source [SID1234615423]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Chief Executive Officer Harout Semerjian and Chief Financial Officer Brian Hahn will attend in person. Research Analyst Roger Song, M.D. will host a fireside chat with Mr. Semerjian. An archived recording of the chat will be available for thirty days on the GlycoMimetics website at View Source, beginning Wednesday, June 8 at approximately 3:30 p.m. ET.